HomeCompareMGRM vs KO

MGRM vs KO: Dividend Comparison 2026

MGRM yields 33.33% · KO yields 2.70%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGRM wins by $126.1K in total portfolio value
10 years
MGRM
MGRM
● Live price
33.33%
Share price
$6.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$160.1K
Annual income
$23,203.52
Full MGRM calculator →
KO
The Coca-Cola Company
● Live price
2.70%
Share price
$76.27
Annual div
$2.06
5Y div CAGR
24.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.1K
Annual income
$4,303.79
Full KO calculator →

Portfolio growth — MGRM vs KO

📍 MGRM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGRMKO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGRM + KO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGRM pays
KO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGRM
Annual income on $10K today (after 15% tax)
$2,833.33/yr
After 10yr DRIP, annual income (after tax)
$19,722.99/yr
KO
Annual income on $10K today (after 15% tax)
$229.58/yr
After 10yr DRIP, annual income (after tax)
$3,658.22/yr
At 15% tax rate, MGRM beats the other by $16,064.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGRM + KO for your $10,000?

MGRM: 50%KO: 50%
100% KO50/50100% MGRM
Portfolio after 10yr
$97.1K
Annual income
$13,753.65/yr
Blended yield
14.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KO right now

MGRM
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$5.40
-10.0% upside vs current
Range: $5.40 — $5.40
Altman Z
12.6
Piotroski
2/9
KO
Analyst Ratings
29
Buy
16
Hold
3
Sell
Consensus: Buy
Price Target
$84.88
+11.3% upside vs current
Range: $81.00 — $88.00
Altman Z
5.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGRM buys
0
KO buys
0
No recent congressional trades found for MGRM or KO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGRMKO
Forward yield33.33%2.70%
Annual dividend / share$2.00$2.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%24.3%
Portfolio after 10y$160.1K$34.1K
Annual income after 10y$23,203.52$4,303.79
Total dividends collected$113.6K$15.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy
Analyst price target$5.40$84.88

Year-by-year: MGRM vs KO ($10,000, DRIP)

YearMGRM PortfolioMGRM Income/yrKO PortfolioKO Income/yrGap
1← crossover$14,033$3,333.33$10,846$335.73+$3.2KMGRM
2$19,387$4,371.75$11,829$430.64+$7.6KMGRM
3$26,389$5,644.57$12,988$555.50+$13.4KMGRM
4$35,417$7,180.46$14,372$721.34+$21.0KMGRM
5$46,902$9,006.44$16,049$944.01+$30.9KMGRM
6$61,333$11,146.93$18,114$1,246.74+$43.2KMGRM
7$79,249$13,622.82$20,702$1,664.24+$58.5KMGRM
8$101,247$16,450.69$24,008$2,249.48+$77.2KMGRM
9$127,976$19,642.17$28,317$3,085.19+$99.7KMGRM
10$160,138$23,203.52$34,065$4,303.79+$126.1KMGRM

MGRM vs KO: Complete Analysis 2026

MGRMStock

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Full MGRM Calculator →

KOConsumer Staples

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Full KO Calculator →
📬

Get this MGRM vs KO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGRM vs SCHDMGRM vs JEPIMGRM vs OMGRM vs MAINMGRM vs PEPMGRM vs PGMGRM vs JNJMGRM vs MCD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.